UBE2C and cancer: Using ssGSEA, we validated the effect of UBE2C + cancer cells (Epi-C6) on the prognosis of patients with LUAD in the TCGA-LUAD database and found that it can be used as a biomarker for predicting the prognosis of LUAD (Fig. 2f).